JPRN-UMIN000009109已完成未知
GI endoscopy and anticoagulant therapy -a multicenter obsevational study- - Osaka GI-anticoagulant (GIANT) study
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine0 个研究点目标入组 450 人开始时间: 2012年10月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 450
研究概览
简要总结
DOAC administration showed similar post-procedural GI bleeding risk to VKA administration in patients undergoing endoscopic procedures, but it shortened the hospital stay.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with unstable vital sign with high risk of endoscopy. 2) Patients with apparent GI bleeding before endoscopy. 3)Pregnant, breast-feeding women and possibility of pregnancy 4)Patients who will perform endoscopic biopsy and treatment during the same hospitalization period 5)Patients who were considered not suitable to be included in this study by the physician.
研究者
相似试验
已完成
4 期
Argon Plasma Coagulation for Bleeding Peptic UlcersBleeding UlcersNCT02241044Kaohsiung Veterans General Hospital.116
Unknown
4 期
Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal RebleedingLiver Cirrhosis and Hepatoma.Gastric Variceal BleedingNCT00567216Taipei Veterans General Hospital, Taiwan120
已完成
不适用
Anticoagulation in Emergency General SurgeryEmergency General SurgeryNCT04216394Methodist Health System4
Unknown
不适用
Endoscopic Treatment of Non-variceal Upper GI-bleeding With High Risk of Recurrency - OTSC (Over-the-scope-clip) Versus Standard Therapy (STING2)Acute Upper Gastrointestinal HemorrhageNCT03331224Kliniken Ludwigsburg-Bietigheim gGmbH120
Unknown
4 期
The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis:A Multicenter RCTPortal Vein ThrombosisLiver CirrhosisNCT02630095Shanghai Zhongshan Hospital96
